News

Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
As Medadvisor's divestment deal today attests, foreign acquirers are on the hunt for undervalued local assets. ... Read More ...